IL240236B - A pharmaceutical preparation containing salinosporamides and a production item containing packaging material and the pharmaceutical preparation - Google Patents
A pharmaceutical preparation containing salinosporamides and a production item containing packaging material and the pharmaceutical preparationInfo
- Publication number
- IL240236B IL240236B IL240236A IL24023615A IL240236B IL 240236 B IL240236 B IL 240236B IL 240236 A IL240236 A IL 240236A IL 24023615 A IL24023615 A IL 24023615A IL 240236 B IL240236 B IL 240236B
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical composition
- salinosporamides
- article
- manufacture
- packaging material
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/600,854 US7179834B2 (en) | 2002-06-24 | 2003-06-20 | Salinosporamides and methods for use thereof |
US10/838,157 US7176232B2 (en) | 2002-06-24 | 2004-04-30 | Salinosporamides and methods for use thereof |
PCT/US2004/019453 WO2005003137A1 (en) | 2003-06-20 | 2004-06-18 | Salinosporamides and methods for use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
IL240236A0 IL240236A0 (en) | 2015-09-24 |
IL240236B true IL240236B (en) | 2021-02-28 |
Family
ID=46713688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL240236A IL240236B (en) | 2003-06-20 | 2015-07-30 | A pharmaceutical preparation containing salinosporamides and a production item containing packaging material and the pharmaceutical preparation |
Country Status (8)
Country | Link |
---|---|
KR (1) | KR101315595B1 (ko) |
CY (1) | CY1116724T1 (ko) |
DK (1) | DK2441767T3 (ko) |
ES (1) | ES2546415T3 (ko) |
IL (1) | IL240236B (ko) |
MX (1) | MX361003B (ko) |
PT (1) | PT2441767E (ko) |
SI (1) | SI2441767T1 (ko) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4322802A (en) | 2000-11-16 | 2002-06-24 | Univ California | Marine actinomycete taxon for drug and fermentation product dicovery |
-
2004
- 2004-06-18 KR KR1020127016459A patent/KR101315595B1/ko active IP Right Grant
- 2004-06-18 SI SI200432255T patent/SI2441767T1/sl unknown
- 2004-06-18 MX MX2013010748A patent/MX361003B/es unknown
- 2004-06-18 ES ES11163737.7T patent/ES2546415T3/es not_active Expired - Lifetime
- 2004-06-18 DK DK11163737.7T patent/DK2441767T3/en active
- 2004-06-18 PT PT111637377T patent/PT2441767E/pt unknown
-
2015
- 2015-07-30 IL IL240236A patent/IL240236B/en active IP Right Grant
- 2015-08-25 CY CY20151100744T patent/CY1116724T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT2441767E (pt) | 2015-10-09 |
SI2441767T1 (sl) | 2015-10-30 |
KR20120081637A (ko) | 2012-07-19 |
KR101315595B1 (ko) | 2013-10-08 |
IL240236A0 (en) | 2015-09-24 |
ES2546415T3 (es) | 2015-09-23 |
CY1116724T1 (el) | 2017-03-15 |
DK2441767T3 (en) | 2015-08-24 |
MX361003B (es) | 2018-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003267313A8 (en) | Packaging material and containers formed therefrom | |
GB2406305B (en) | Compostable packaging materials and methods | |
IL213597A0 (en) | Compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments | |
EP1447433A4 (en) | COATING MATERIAL COMPOSITION AND ARTICLE COMPRISING A COATING FILM FORMED WITH THE SAME | |
IL173602A0 (en) | Heteroarylaminosulfonylphenyl derivatives and pharmaceutical compositions containing the same | |
IL173627A0 (en) | 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives and pharmaceutical compositions containing the same | |
IL164021A (en) | Anti-αvβ6 antibodies and their pharmaceutical preparations | |
IL173051A0 (en) | N-glucoside derivatives and pharmaceutical compositions containing the same | |
IL171997A0 (en) | Pyrrolodihydroisoquinoline derivatives and pharmaceutical compositions containing the same | |
IL175214A0 (en) | 2-cyanopyrrolidinecarboxamide derivatives and pharmaceutical compositions containing the same | |
IL172159A0 (en) | 2-oxo-pyridine derivatives and pharmaceutical compositions containing the same | |
EP1418272A4 (en) | PACKAGING MATERIAL AND CONTAINER | |
IL162548A0 (en) | 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same | |
IL166482A0 (en) | Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same | |
IL176384A (en) | Pyrrolidinochlorinated basazole and pharmacy preparations containing them | |
AU2003227199A8 (en) | Packaging material and packaging bag | |
SI1664050T1 (sl) | Nevroprotektične biciklične spojine in farmacevtski sestavki, vsebujoči le-te | |
HK1097746A1 (en) | Oligopeptides as coating material for medical products | |
AU2003211476A8 (en) | Packaging material and packaging container | |
IL179669A0 (en) | Benzoimidazole derivatives and pharmaceutical compositions containing the same | |
AP2127A (en) | Multi-carbide material manufacture and use | |
EP1704843A4 (en) | PACKAGING MATERIAL AND PACKAGING FOR A MEDICAL INSTRUMENT SET | |
IL240236A0 (en) | A pharmaceutical preparation containing salinosporamides and a manufacturing item containing packaging material and the pharmaceutical preparation | |
GB0224848D0 (en) | Packaging and packaging material | |
NO20043859L (no) | Pulversammensetning inneholdende zaleplon med definert partikkelstorrelsesfordeling og farmasoytiske produkter derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed |